Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Choosing wisely: Cancer care in Africa

AORTIC 2019 Conference

Published: 7 Feb 2020

Views: 776

Rating:

Save

Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda

Dr Fidel Rubagumya speaks to ecancer at the 2019 AORTIC conference in Maputo about the "choosing wisely" campaign.

He provides an overview of this campaign, which encourages the practice of evidence-based medicine and the need for African healthcare professionals to choose wisely.

Dr Rubagumya also discusses human rights in cancer care - in which he believes healthcare equity and medical access should be a basic right for all patients in low- and middle-income settings.

Related Videos

Innovating cancer care access for low and middle-income countries

Lacy Hubbard - Founding President and CEO, Elekta Foundation

Innovating cancer care access for low and middle-income countries ( Lacy Hubbard - Founding President and CEO, Elekta Foundation )

Innovation in cancer treatment and equity: ensuring emerging treatments reach all populations

Dr Dario Trapani - European Institute of Oncology, IRCCS, Milan, Italy

Innovation in cancer treatment and equity: ensuring emerging treatments reach all populations ( Dr Dario Trapani - European Institute of Oncology, IRCCS, Milan, Italy )

Prostate cancer

Dr Alison Tree - Institute of Cancer Research, London, UK

Prostate cancer ( Dr Alison Tree - Institute of Cancer Research, London, UK )

Rectal cancer

Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada

Rectal cancer ( Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada )

Synthetic biology and precision medicine in blood and gynaecological cancers

Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa

Synthetic biology and precision medicine in blood and gynaecological cancers ( Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa )

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC

Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC ( Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA )

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

NSIA and Nigeria to improve treatment for Nigerians through the building of new cancer centres

Aminu Umar-Sadiq - MD & CEO, Nigeria Sovereign Investment Authority (NSIA)

NSIA and Nigeria to improve treatment for Nigerians through the building of new cancer centres ( Aminu Umar-Sadiq - MD & CEO, Nigeria Sovereign Investment Authority (NSIA) )

Time toxicity: the burden on cancer patients

Dr Arjun Gupta - University of Minnesota, Minneapolis, USA

Time toxicity: the burden on cancer patients ( Dr Arjun Gupta - University of Minnesota, Minneapolis, USA )

More from ecancer